Athena Gierbolini, president of Hope for HS, a nonprofit advocacy group for those affected with hidradenitis suppurativa (HS), spoke on common stigmas regarding HS and how clinicians can improve consultation through a culturally sensitive approach.
There are several misconceptions regarding hidradenitis suppurativa (HS) that clinicians should address with a culturally sensitive approach, said Athena Gierbolini, president of Hope for HS, a nonprofit advocacy group for those affected with HS.
Transcript
Can you speak on misconceptions in the management of HS?
We understand fully that cigarette smoking and weight loss are very important topics. Cigarette smoking can kill you—it's been proven, it's very bad for you—and being overweight is indicative of being unhealthy and we get that, too. If I meet a doctor, and in the first 30 minutes, they tell me that I need to quit smoking and lose weight, I kind of tune them out.
We are working, as the patient community, to kind of help doctors understand that we have organized online and we know a lot of patients who are thin that have this disease. There are patients who have anorexia that have this disease. And again, I'm not saying that we shouldn't be trying to incorporate a healthy diet into our lifestyle, that smoking isn't horrible for you—it absolutely is—but maybe that can be a nudge in the second or third appointment and done gently.
This reputation that patients with HS have that we’re overweight smokers only leads into more of this stigma that we are doing this to ourselves. If it were as simple as that we would do this, but it's a little more complex than that.
Hospital Stays and Probable Dementia as Predictors of Relocation to Long-Term Care Facilities
October 22nd 2024This article explores late-life relocations in patients with dementia, hospital stays, and their implications for health care policy, geriatric care, and future research priorities.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
October 21st 2024Examining care transitions in hospitalized patients revealed lower diagnostic error rates compared with traditional methods, highlighting the effectiveness of this approach in identifying diagnostic challenges.
Read More
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
October 20th 2024The case study, which showed prolonged disease control achieved with gilteritinib in a previously-treated patient with AML with an inv(2)(p23q13) translocation, indicates that gilteritinib can also be used as an anaplastic lymphoma kinase (ALK) inhibitor.
Read More